Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-20

Clinical Trial Update: 30% or 60% Oxygen at Birth to Improve Neurodevelopmental Outcomes in Very Low Birthweight Infants [NA]

View source ↗

Summary

This clinical trial is evaluating whether providing 30% or 60% oxygen at birth improves neurodevelopmental outcomes in very low birthweight infants; recruitment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alberta | Conditions: Premature Infant, Respiratory Distress Syndrome in Premature Infant | NA | Status: RECRUITING